Retraction Note: Targeting of colorectal cancer growth, metastasis, and anti-apoptosis in BALB/c nude mice via APRIL siRNA (Molecular and Cellular Biochemistry, (2012), 363, (1–10), 10.1007/s11010-011-1151-4);Targeting of colorectal cancer growth, metastasis, and anti-apoptosis in BALB/c nude mice via APRIL siRNA

Molecular and Cellular Biochemistry

Volumn 363, Issue 1-2, 2012, Pages 1-10

  Wang, Jingchun ^a   Ding, Weifeng ^a   Sun, Baolan ^a   Jing, Rongrong ^a   Huang, Hua ^a   Shi, Gongsheng ^a   Wang, Huimin ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Apoptosis; Colorectal cancer; Metastasis; Nude; Proliferation; RNA interference

Indexed keywords

APRIL PROTEIN; EOSIN; GELATINASE A; GELATINASE B; HEMATOXYLIN; KI 67 ANTIGEN; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; SMALL INTERFERING RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELL DEATH; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; STAINING; TUMOR GROWTH; TUMOR XENOGRAFT;

MUS MUSCULUS;

EID: 84857895476     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-022-04567-1     Document Type: Erratum

References (45)

1. Cohen AM, Minsky BD, Schilsky RL (1997) Cancer of the colon. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 5th edn. Lippincott-Raven, Philadelphia, pp 1144-1196
2. Parker SL, Tong T, Bolden S et al (1997) Cancer statistics. CA Cancer J Clin 47:5-27
3. Leichman CG, Flemming T, Muggia FM et al (1995) Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest oncology group study. J Clin Oncol 13:1303-1311
4. Marsh JC, Bertino JR, Katy KH et al (1991) The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancer. J Clin Oncol 9:371-380
5. Hahne M, Kataoka T, Schröter M et al (1998) APRIL, a new ligand of the tumor necrosisfactor family, stimulates tumor cell growth. J Exp Med 188:1185-1190 (Pubitemid 28443341)
6. Pradet-Balade B, Medema JP, López-Fraga M et al (2002) An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein. EMBO J 21:5711-5720 (Pubitemid 35315271)
7. Roth W, Wagenknecht B, Klumpp A et al (2001) APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis. Cell Death Differ 8:403-410 (Pubitemid 32409611)
8. Nishio M, Endo T, Tsukada N et al (2005) Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha. Blood 106:1012-1020 (Pubitemid 41076448)
9. Endo T, Nishio M, Enzler T et al (2007) BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway. 2002; Blood 109:703-710 (Pubitemid 46105972)
10. Novak AJ, Bram RJ, Kay NE et al (2002) Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival. Blood 100:2973-2979
11. Rennert P, Schneider P, Cachero TG et al (2000) A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. J Exp Med 192:1677-1684
12. Kelly K, Manos E, Jensen G et al (2000) APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death. Cancer Res 60:1021-1027 (Pubitemid 30129540)
13. Fire A, Xu S, Montgomery MK et al (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806-811 (Pubitemid 28099681)
14. Elbashir SM, Harborth J, Lendeckel W et al (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498 (Pubitemid 32494397)
15. Elbashir SM, Lendeckel W, Tuschl T (2001) RNA interference is mediated by 21-and 22-nucleotide RNAs. Genes 15:188-200 (Pubitemid 32107664)
16. Zhang L, Gao LF, Li Y et al (2008) Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth. Clin Cancer Res 14:559-568 (Pubitemid 351226126)
17. Takei Y, Nemoto T, Mu P et al (2008) In vivo silencing of a molecular target by short interfering RNA electroporation: tumor vascularization correlates to delivery efficiency. Mol Cancer Ther 7:211-221
18. Singh RP, Tyagi A, Sharma G et al (2008) Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving downregulation of survivin. Clin Cancer Res 14:300-308 (Pubitemid 351378006)
19. O'Reilly MS, Boehm T, Shing Y et al (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277-285 (Pubitemid 28015876)
20. Ding W, Wang J, Sun B et al (2009) APRIL knockdown suppresses migration and invasion of human colon carcinoma cells. Clin Biochem 42:1694-1698
21. Allred DC, Harvey JM, Berardo M et al (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11:155-168 (Pubitemid 28144151)
22. Mackay F, Tangye SG (2004) The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers. Curr Opin Pharmacol 4:347-354 (Pubitemid 38987060)
23. Klein B, Tarte K, Jourdan M et al (2003) Survival and proliferation factors of normal and malignant plasma cells. Int J Hematol 78:106-113 (Pubitemid 37021949)
24. Moreaux J, Legouffe E, Jourdan E et al (2004) BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexa-methasone. Blood 103:3148-3157 (Pubitemid 38451693)
25. Tsurimoto T (1998) PCNA, a multifunctional ring on DNA. Biochim Biophys Acta 1443:23-39
26. Bravo R, Frank R, Blundell PA et al (1987) Cyclin/PCNA is the auxiliary protein of DNA polymerase delta. Nature 326:515-517 (Pubitemid 17055498)
27. Zhang W, Meng R, Fu C et al (2002) Gene expression significance of h-catenin, p53 and PCNA in PJS polyposis. Zhonghua Wai Ke Za Zhi 40:104-106
28. Suh N, Paul S, Hao X et al (2007) Pterostilbene, an active constituent of blueberries, suppresses aberrant cryptfoci formation in the azoxymethane-induced colon carcinogenesis modelin rats. Clin Cancer Res 13:350-355 (Pubitemid 46121889)
29. Kohno H, Suzuki R, Curini M et al (2006) Dietary administration with prenyloxycoumarins, auraptene and collinin, inhibits colitis-related colon carcinogenesis in mice. Int J Cancer 118:2936-2942
30. Lim DY, Tyner AL, Park JB et al (2005) Inhibition of colon cancer cell proliferation by the dietary compound conjugated linoleic acid is mediated by the CDK inhibitor p21CIP1/WAF1. J Cell Physiol 205:107-113 (Pubitemid 41262856)
31. Nomoto H, Iigo M, Hamada H et al (2004) Chemoprevention of colorectal cancer by grape seed proanthocyanidin is accompanied by a decrease in proliferation and increase in apoptosis. Nutr Cancer 49:81-88 (Pubitemid 39299130)
32. Jansen RL, Hupperets PS, Arends JW et al (1998) MIB-1 labelling index is an independent prognostic marker in primary breast cancer. Br J Cancer 78:460-465 (Pubitemid 28360632)
33. Perry A, Stafford SL, Scheithauer BW et al (1998) The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82:2262-2269 (Pubitemid 28240835)
34. Mashal RD, Lester S, Corless C et al (1996) Expression of cell cycle regulated proteins in prostate cancer. Cancer Res 56:4159-4163 (Pubitemid 26305010)
35. Gerdes J, Dallenbach F, Lennert K et al (1984) Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol Oncol 2:365-371 (Pubitemid 15151580)
36. Williams GT, Smith CA (1993) Molecular regulation of apoptosis: genetic controls on cell death. Cell 74:777-779 (Pubitemid 23270597)
37. Adams JM, Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281:1322-1326 (Pubitemid 28406819)
38. Matrisian LM (1999) Cancer biology: extracellular proteinases in malignancy. Curr Biol 9:R776-R778
39. Kleiner DE, Stetler-Stevenson WG (1999) Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 43:S42-S51 (Pubitemid 29244632)
40. Yu Q, Stamenkovic I (1999) Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 13:35-48 (Pubitemid 29045114)
41. Karadag A, Ogbureke KU, Fedarko NS et al (2004) Bone sialoprotein, matrix metalloproteinase 2, and (v)h3 integrin in osteotropic cancer cell invasion. J Natl Cancer Inst 96:956-965 (Pubitemid 38868142)
42. Deryugina EI, Bourdon MA, Luo GX et al (1997) Matrix metalloproteinase-2 activation modulates glioma cell migration. J Cell Sci 110:2473-2482 (Pubitemid 127699161)
43. Nagase H, Woessner JF Jr (1999) Matrix metalloproteinases. J Biol Chem 274:21491-21494 (Pubitemid 129519680)
44. Brew K, Dinakarpandian D, Nagase H (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 7:1-2
45. Leco KJ, Khokha R, Pavloff N et al (1994) Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 269:9352-9360 (Pubitemid 24209266)